Payer Games

The denial code is not the argument. What’s in a complete claim file beyond the 835, the five contradictions worth looking for, and what the appeal that wins actually presents.

Three tools most practices never use: expedited review, which puts a physician on record within 72 hours; peer to peer, which makes the medical director defend the denial out loud; and Independent Medical Review, which is binding. How to use them in sequence.

After the IRA Maximum Fair Price took effect, UnitedHealthcare’s clinical system kept approving Eliquis while its pharmacy benefit system blocked it. One stable patient went five days without anticoagulation. The contradiction that reverses it is in the payer’s own letters.

A write-off is where the damage starts. What practices quietly change after a denied high-cost claim: pulled protocols, switched drugs, consolidated sites and interrupted maintenance regimens, and why most of it traces back to a payer system error.

New J-codes activate faster in payer clinical systems than in fee schedules, and every claim in the gap comes back CO-96. Eight Q2 and Q3 2026 codes, the trap on each, and the CO-45 contradiction that reverses them before timely filing closes.

Why the documentation argument fails on a whole category of denials, and how reading the payer’s full correspondence as one system surfaces contradiction arguments: six examples, three questions to ask on every live denial.

Five automated payer barriers we see across independent specialty practices, from fee schedule lag on new J-codes to step therapy denials issued without exception review, and why the payer’s own records are what overturn them.